학술논문
577O PRINCE: Interim analysis of the phase Ib study of 177Lu-PSMA-617 in combination with pembrolizumab for metastatic castration resistant prostate cancer (mCRPC)
Document Type
Abstract
Author
Source
In Annals of Oncology September 2021 32 Supplement 5:S626-S627
Subject
Language
ISSN
0923-7534